NCT00002051View on ClinicalTrials.gov

Double Blind Study of Thymopentin Effects on Patients With HIV-1 Infection

NACompletedINTERVENTIONAL
Timeline

Start Date

Not specified

Conditions
HIV Infections
Interventions
DRUG

Thymopentin

Trial Locations (1)

088010999

Immunobiology Research Institute, Annandale

Sponsors
All Listed Sponsors
lead

Immunobiology Research Institute

INDUSTRY

NCT00002051 - Double Blind Study of Thymopentin Effects on Patients With HIV-1 Infection | Biotech Hunter | Biotech Hunter